The Early Achievement of Measurable Residual Disease Negativity in the Treatment of Adults with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia is a Strong Predictor for Survival

被引：0

作者：

Yilmaz, Musa ^{[1
]}

Kantarjian, Hagop ^{[1
]}

Wang, Xuemei ^{[2
]}

Loghavi, Sanam ^{[3
]}

Khoury, Joseph ^{[3
]}

Jorgensen, Jeffrey ^{[3
]}

Ravandi, Farhad ^{[1
]}

Short, Nicholas ^{[1
]}

Cortes, Jorge ^{[1
]}

Garcia-Manero, Guillermo ^{[1
]}

Kadia, Tapan ^{[1
]}

Sasaki, Koji ^{[1
]}

Konopleva, Marina ^{[1
]}

Takahashi, Koichi ^{[1
]}

Wierda, William ^{[1
]}

Khouri, Maria ^{[1
]}

Jain, Nitin ^{[1
]}

Verstovsek, Srdan ^{[1
]}

Estrov, Zeev ^{[1
]}

Bose, Prithviraj ^{[1
]}

Pierce, Sherry ^{[1
]}

Garris, Rebecca ^{[1
]}

O'Brien, Susan ^{[4
]}

Jabbour, Elias ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA

[4] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Orange, CA 92668 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷

关键词：

minimal residual disease; ALL; survival; early; acute lymphoblastic leukemia;

D O I：

10.1016/j.clml.2019.07.040

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ALL-280

引用

页码：S193 / S194

页数：2

共 50 条

[1] The Early Achievement of Measurable Residual Disease Negativity in the Treatment of Adults with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia Is a Strong Predictor for Survival
Yilmaz, Musa
Kantarjian, Hagop M.
Wang, Xuemei
Khoury, Joseph D.
Ravandi, Farhad
Jorgensen, Jeffrey L.
Short, Nicholas J.
Loghavi, Sanam
Cortes, Jorge E.
Garcia-Manero, Guillermo
Kadia, Tapan M.
Sasaki, Koji
Konopleva, Marina Y.
Takahashi, Koichi
Wierda, William G.
Jain, Nitin
Verstovsek, Srdan
Estrov, Zeev E.
Bose, Prithviraj
Pierce, Sherry A.
Garris, Rebecca
O'Brien, Susan M.
Jabbour, Elias
BLOOD, 2019, 134
[2] The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia-negative B-cell acute lymphoblastic leukemia is a strong predictor for survival
Yilmaz, Musa
Kantarjian, Hagop
Wang, Xuemei
Khoury, Joseph D.
Ravandi, Farhad
Jorgensen, Jeffrey
Short, Nicholas J.
Loghavi, Sanam
Cortes, Jorge
Garcia-Manero, Guillermo
Kadia, Tapan
Sasaki, Koji
Konopleva, Marina
Takahashi, Koichi
Wierda, William
Jain, Nitin
Verstovsek, Srdan
Estrov, Zeev
Bose, Prithviraj
Pierce, Sherry
Garris, Rebecca
O'Brien, Susan
Jabbour, Elias
AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (02) : 144 - 150
[3] Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
Enrico Maffini
Francesco Saraceni
Francesco Lanza
Clinical Hematology International, 2019, 1 (2) : 85 - 93
[4] Prognostic Index for Survival in Adult Patients with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia (ALL)
Yilmaz, Musa
Kantarjian, Hagop M.
Wang, Xuemei
Devendra, K. C.
Khoury, Joseph David
Ravandi, Farhad
Short, Nicholas J.
Cortes, Jorge E.
Garcia-Manero, Guillermo
Kadia, Tapan
Sasaki, Koji
Konopleva, Marina
Wierda, William G.
Khouri, Maria
Jain, Nitin
Verstovsek, Srdan
Estrov, Zeev
Bose, Prithviraj
Pierce, Sherry
Garris, Rebecca
O'Brien, Susan M.
Jabbour, Elias J.
BLOOD, 2017, 130
[5] Measurable residual disease in childhood B-cell acute lymphoblastic leukemia
Gale, Robert Peter
BLOOD SCIENCE, 2022, 4 (04): : 209 - 210
[6] Comorbidities Reduce Response to Induction Treatment and Survival in Adults with Philadelphia-Negative Acute Lymphoblastic Leukemia
Tanasi, Ilaria
Tagliaferri, Veronica
Tecchio, Cristina
Aprili, Fiorenza
De Matteis, Giovanna
Pizzolo, Giovanni
Krampera, Mauro
Bonifacio, Massimiliano
BLOOD, 2019, 134
[7] Dynamics of Measurable Disease at Remission Determines Survival in Patients (Pts) with Philadelphia Chromosome Negative B-Cell Acute Lymphoblastic Leukemia (ALL)
Yilmaz, Musa
Jabbour, Elias J.
Wang, Xuemei
Loghavi, Sanam
Khoury, Joseph David
Jorgensen, Jeffrey L.
Ravandi, Farhad
Short, Nicholas J.
Cortes, Jorge E.
Garcia-Manero, Guillermo
Kadia, Tapan
Sasaki, Koji
Konopleva, Marina
Takahashi, Koichi
Khouri, Maria
Jain, Nitin
Verstovsek, Srdan
Estrov, Zeev
Estrov, Zeev
Bose, Prithviraj
Pierce, Sherry
Garris, Rebecca
O'Brien, Susan M.
Kantarjian, Hagop M.
BLOOD, 2017, 130
[8] Early achievement of measurable residual disease negativity in the treatment of multiple myeloma as predictor of outcome
Baumelou, Marion
Payssot, Alexandre
Row, Celine
Racine, Jessica
Lafon, Ingrid
Bastie, Jean-Noel
Chevreux, Steeve
Chretien, Marie-Lorraine
Maynadie, Marc
Caillot, Denis
Guy, Julien
BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 (06) : E82 - E85
[9] Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in Japan
T Imamura
N Kiyokawa
M Kato
C Imai
Y Okamoto
M Yano
K Ohki
Y Yamashita
Y Kodama
A Saito
M Mori
S Ishimaru
T Deguchi
Y Hashii
Y Shimomura
T Hori
K Kato
H Goto
C Ogawa
K Koh
T Taki
A Manabe
A Sato
A Kikuta
S Adachi
K Horibe
A Ohara
A Watanabe
Y Kawano
E Ishii
H Shimada
Blood Cancer Journal, 2016, 6 : e419 - e419
[10] Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in Japan
Imamura, T.
Kiyokawa, N.
Kato, M.
Imai, C.
Okamoto, Y.
Yano, M.
Ohki, K.
Yamashita, Y.
Kodama, Y.
Saito, A.
Mori, M.
Ishimaru, S.
Deguchi, T.
Hashii, Y.
Shimomura, Y.
Hori, T.
Kato, K.
Goto, H.
Ogawa, C.
Koh, K.
Taki, T.
Manabe, A.
Sato, A.
Kikuta, A.
Adachi, S.
Horibe, K.
Ohara, A.
Watanabe, A.
Kawano, Y.
Ishii, E.
Shimada, H.
BLOOD CANCER JOURNAL, 2016, 6 : e419 - e419

← 1 2 3 4 5 →